NCT06424093

Brief Summary

Performing out patient diagnostic and operative gynecological procedures is becoming more popular having the benefits of reducing risks of general anaesthetia, decreasing healthcare burden and increasing satisfaction for both patient and provider. Virtual reality (VR), a new technology, has been studied as a distraction technique for non-pharmacological method of pain relief. It is a computer-generated representation of an immersive videos viewed through a headset.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

May 11, 2024

Last Update Submit

May 16, 2024

Conditions

Keywords

hysteroscopyAcute PainAnxietyVirtual Reality

Outcome Measures

Primary Outcomes (1)

  • Assessment of Pain

    The pain level of the cases is evaluated by means of the digital pain as the 11-point visual analog scale (VAS) whereas 0-Represents no pain, 10 - Worst imaginable pain), as well as the 11-point VAS-A (0-Represents no anxiety, 10 - Highest anxiety)

    10 minutes from starting the procedure

Study Arms (2)

Group A: Cases Group

EXPERIMENTAL

About 25 women indicated for diagnostic hysteroscopy with using Virtual Reality Technology

Procedure: Virtual Reality Technology

Group B: Control Group

PLACEBO COMPARATOR

About 25 women indicated for diagnostic hysteroscopy without using Virtual Reality Technology

Procedure: Virtual Reality Technology

Interventions

To evaluate the role of virtual reality technology as distraction technique in the management of acute pain during outpatient hysteroscopy

Also known as: Hysteroscopy
Group A: Cases GroupGroup B: Control Group

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- Patients scheduled for diagnostic hysteroscopy e.g. Infertility, AUB

You may not qualify if:

  • Absolute contraindication to office hysteroscopy such as acute pelvic infection , active genital herpes , heavy bleeding or pregnancy.
  • Psychological ,hearing or visual disorders.
  • known anatomical condition that make performing office hysteroscopy is difficult such as cervical stenosis ,fibrosis or cervical amputation .
  • Previous history of failed office hysteroscopy
  • Patients scheduled for operative hysteroscopy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Hospitals

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Acute PainAnxiety Disorders

Interventions

Hysteroscopy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeObstetric Surgical ProceduresGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Amr Elhussieny, Professor

    Head of Obstetrics and Gynecology department , Faculty of Medicine, Ain Shams University

    STUDY CHAIR
  • Mortada El Sayed Ahmed, Professor

    Department of obstetrics & gynecology, Faculty Of Medicine, Ain Shams University

    STUDY DIRECTOR
  • Radwa Rsaheedy Ali, M.D

    Department of obstetrics & gynecology, Faculty Of Medicine, Ain Shams University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Waleed Mohamed shawky, MSC

CONTACT

Tarek Sabry Mohamed, MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2024

First Posted

May 21, 2024

Study Start

May 1, 2024

Primary Completion

November 1, 2024

Study Completion

November 15, 2024

Last Updated

May 21, 2024

Record last verified: 2024-05

Locations